Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
This study investigated the impact of the COVID-19 pandemic on alcohol-related liver disease in the summer of 2020 compared with the same period in 2016-2019.
This study examined trends over time of HCV-associated hepatocellular carcinoma. How has incidence changed since the introduction of IFN-free therapies?
All-oral daclatasvir plus asunaprevir for chronic hepatitis C virus (HCV) genotype 1b infection: a sub-analysis in Asian patients from the HALLMARK DUAL study.